Generic Pharmaceutical Association issues statement on H.R. 5629 biologics bill
Generic Pharmaceutical Association President/CEO Kathleen Jaeger issued a statement on the introduction this week of H.R. 5629, the "Pathway to Biosimilars Act." The
